Table of Contents

What is CBDV? Definition and properties

If you’ve been wondering what CBDV is and what its effects are, you’re in luck. In this article we tell you what CBDV is according to its effects and what the most important scientific advances are.

What is CBDV?

CBDV is a non-psychoactive compound found in Cannabis. It is very similar to cannabidiol (CBD), only molecularly it has some differences. This is why it has several similar effects and in some cases can have similar functions.

CBDV is found in high levels in wild Indica plants. These plants have been found more than all of northeast India and northern Nepal. But they can also be found in genetically modified plants produced by laboratories.

Properties of CBDV

The CBDV as a compound was identified by Vollner and his collaborators in 1969. Since then its development has been overshadowed by CBD, another cannabinoid with great medicinal potential. Currently the company leading research on it is GW Pharmaceuticals.

Analgesic

What is CBDV?

One of the main properties of CBDV is its analgesic power. CBDV acts at a neurological level and blocks the neurotransmitters responsible for pain. Among them, TRPV1. Thanks to this action, CBDV can eliminate chronic pain.

This is one of the most valued properties of CBDV. In fact, several millennia ago some species of marijuana were already used to treat joint pain. Resins and other compounds were also used locally to treat skin pain.

Smoking marijuana or any other herb is not recommended for chronic joint pain. But to get CBDV you don’t have to smoke. In fact, you can get several medications that contain it as an extract.

It is currently used to treat the pain of arthritis, osteoarthritis, chemotherapy and the effects of HIV. The effects of the extract have been shown to be quite safe. It has even been shown to cause fewer side effects than other conventional painkillers.

Anticonvulsant

What is CBDV? CBDV is a powerful anticonvulsant. Several studies have positioned it as a promising drug for eliminating and lowering the intensity of seizures. While it could hardly function as a neuromodulator.

CBDV has been tested on rodent brain tissue by the University of Reading and the Otsuka Pharmaceutical Group. Its application on these tissues has been shown to reduce and intensity of epileptic seizures. It has even eventually slowed them down.

Its effect is due to the fact that it acts as an antagonist of the TRPV1 receptor. For this reason it not only slows down the activity of this neuroreceptor, acting as an adjuvant in various cases of epilepsy. It is hoped that further research can be done because CBDV has few side effects.

To achieve this effect one must be exposed to considerable doses for a long time. However, it is expected that a standardization will be carried out soon. Especially to treat various epileptic conditions.

Another notorious aspect is that CBDV decreases the expression of epilepsy-related genes in certain tissues. This was demonstrated by a study formulated to understand the effect of CBDV at the molecular level.

Although there are other effective antiepileptic drugs, CBDV has the advantage of not affecting motor functions. This makes it a good candidate as an adjuvant, especially in children and older adults.

It will probably be easy to find a doctor with CBDV in our trusted pharmacy in a short time. This would be ideal, as the non-invasive and liver-friendly effects make it an ideal alternative.

Adjuvant against Rett syndrome

Rett syndrome is a specifically female neurological disorder. It is caused by mutations on the X chromosome, so it is a genetic disease. Although it is rare, a sizable population in the world suffers from it.

Its symptomatology is diverse. It is characterized by impaired cognitive abilities and sensory functions. It can also cause emotional disorders and severe motor deficiencies, such as autonomic movement.

The deterioration of autonomic functions is usually the most notable. Especially by involuntary hand movement, slow brain growth, seizures and mental retardation.

Because it is a genetic disease, CBDV cannot help to reverse it. But it can help slow down the deterioration of the parts of the brain affected by the syndrome. This would also help improve the development of life in people with this condition.

This is what several studies conducted in rats by GW Pharma have shown. Naturally, more standardization and more studies are needed. But CBDV is definitely an adjuvant in the treatment of Rett syndrome.

Adjuvant against DMD

What is CBDV?

Duchenne muscular dystrophy is a syndrome that irreversibly affects the bone and muscle system. In addition to tissue damage, it can cause chronic inflammation. It can also cause autoimmune syndromes and severe intestinal disruptions.

A study published in the first half of 2019 in the British Journal of Pharmacology showed the influence of CBDV on the treatment of DMD. According to the researchers, CBDV showed a positive effect on muscle function.

It was also beneficial in stopping dystrophy in rodents and reducing inflammation. It even showed that locomotion problems could be significantly improved. Although the drug has not been tested in humans, it shows promise.

CBDV also showed significant positive effects against gastrointestinal inflammation. The improvement in mice with intestinal disorders demonstrated its possible effects on irritable bowel syndrome and Crohn’s syndrome.

Cannabinoid therapy to treat DMD is still in the early stages. Research suggests that CBDV treatment may improve the response in humans to DMD and combat it less invasively.

Antiemetic

What is CBDV?

The Department of Psychology and Neuroscience Graduate Program at the University of Guelph presented results in animals. The results are from a study in rats in which the animals were induced to nausea.

Although rats cannot vomit, there are certain behaviors that have been identified in rats when they are nauseous. Various chemicals given to them caused these behaviors.

The group of rats given CBDV had fewer behaviors associated with nausea. Some even showed none of these behaviors. This confirms the use many people make of marijuana during chemotherapy, the nausea reducer.

In short, CBDV is an antiemetic, but it still needs to be standardized to achieve the desired effects. Especially in patients who require greater safety and potency and avoidance of narcotic effects.

CBDV can be much more effective when combined with CBD and THCV. All these compounds act at the neuronal level by disabling the receptors that cause nausea. In fact, it is expected that they may have an effect on diseases such as kinetics.

Anti-inflammatory

What is CBDV?

CBDV is an excellent anti-inflammatory. It serves to calm inflammation of the joints, the gastro-intestinal system of the skin and other organs. And the best thing is that it is not steroid, so it can be taken without negative consequences such as acne.

Its effects are based on the blocking of different neural transmitters. This is why it is highly effective. Even as a treatment to mitigate the effects of genetic disorders or chronic diseases.

A prolonged use of the CBDV extract can help provide important relief to inflammatory processes. Even for processes such as eczema, DSD, arthritis and osteoarthritis. However, significant effects have also been observed in inflammation from trauma.

CBDV even has proven effects as an adjuvant to inflammatory processes with inflammation. Among them, those of the respiratory tract, skin, venous tissue, muscles and eyes.

Adjuvant for autism

CBDV may also function as an adjunct to treat mental and neurological disorders produced by the autism spectrum. A study sponsored by GW Pharma demonstrated its positive effects, offering promising results.

What is CBDV?

CBDV helps to eliminate compulsive behaviors and to calm down violent behaviors. It also improves the cognitive, social and emotional development of people with autism and helps to eliminate seizures.

The benefits shown by rats with 20mg/kg showed a decrease in abnormal behaviors without affecting normal behavior. In humans the dose that has been shown to be effective is 10mg/day.

Additionally, CBDV influences the endocannabinoid system and improves the immune response. Because of the intestinal problems that people with autism are prone to, CBDV can be very helpful.

CBDV does not eliminate these problems, but it can help relieve them. It also will not eliminate gluten or lactose intolerance, but it can improve the response to opportunistic microorganisms. Especially if they grow because of traces of these compounds in food.

It is necessary to check if the medicine is completely safe and to set the doses. It is still expected to be available very soon. A treatment with CBDV could eliminate the secondary symptoms of other medication on the liver and motor side.